James Hippel serves as the Executive Vice President and Chief Financial Officer (CFO) at Bio-Techne Corporation, a global life sciences company focused on developing and manufacturing innovative biological tools. In his role, Hippel is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic leadership has been instrumental in driving Bio-Techne's growth and financial stability, as the company continues to expand its product offerings and global reach. Hippel brings a wealth of experience to his position at Bio-Techne. Prior to joining the company in 2017, he held various senior financial roles at leading organizations in the life sciences and healthcare industries. Notably, he served as the CFO of Tomotherapy Incorporated, a medical device company specializing in cancer treatment, where he played a key role in the company's successful acquisition by Accuray Incorporated. Earlier in his career, Hippel worked at Boston Scientific Corporation, a global medical device company, where he held positions of increasing responsibility in financial planning and analysis. Throughout his tenure at Bio-Techne, Hippel has demonstrated a strong commitment to fostering a culture of innovation and operational excellence. Under his guidance, the company has implemented robust financial strategies that have supported its growth and profitability. His expertise in financial management, coupled with his deep understanding of the life sciences industry, has positioned Bio-Techne for continued success in the years ahead.